Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial

CONTEXT: Mesenchymal stem cells (MSCs) are under evaluation as a therapy for ischemic cardiomyopathy (ICM). Both autologous and allogeneic MSC therapies are possible; however, their safety and efficacy have not been compared. OBJECTIVE: To test whether allogeneic MSCs are as safe and effective as au...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA
Autors principals: Hare, Joshua M., Fishman, Joel E., Gerstenblith, Gary, DiFede Velazquez, Darcy L., Zambrano, Juan P., Suncion, Viky Y., Tracy, Melissa, Ghersin, Eduard, Johnston, Peter V., Brinker, Jeffrey A., Breton, Elayne, Davis-Sproul, Janice, Schulman, Ivonne H., Byrnes, John, Mendizabal, Adam M., Lowery, Maureen H., Rouy, Didier, Altman, Peter, Foo, Cheryl Wong Po, Ruiz, Phillip, Amador, Alexandra, Silva, Jose Da, McNiece, Ian K., Heldman, Alan W.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4762261/
https://ncbi.nlm.nih.gov/pubmed/23117550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2012.25321
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars